Raquela J. Thomas

732 total citations
10 papers, 595 citations indexed

About

Raquela J. Thomas is a scholar working on Molecular Biology, Epidemiology and Genetics. According to data from OpenAlex, Raquela J. Thomas has authored 10 papers receiving a total of 595 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Epidemiology and 3 papers in Genetics. Recurrent topics in Raquela J. Thomas's work include Sphingolipid Metabolism and Signaling (5 papers), Autophagy in Disease and Therapy (3 papers) and Virus-based gene therapy research (2 papers). Raquela J. Thomas is often cited by papers focused on Sphingolipid Metabolism and Signaling (5 papers), Autophagy in Disease and Therapy (3 papers) and Virus-based gene therapy research (2 papers). Raquela J. Thomas collaborates with scholars based in United States and Canada. Raquela J. Thomas's co-authors include Besim Öğretmen, Salih Gencer, Zdzisław M. Szulc, Can E. Senkal, Natalia V. Oleinik, Mohammed Dany, Rose Nganga, Ryan De Palma, Shanmugam Panneer Selvam and Kyla D. Baron and has published in prestigious journals such as Blood, The FASEB Journal and Science Signaling.

In The Last Decade

Raquela J. Thomas

9 papers receiving 590 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Raquela J. Thomas United States 8 479 128 83 83 72 10 595
Shi Hao Tan Singapore 13 419 0.9× 127 1.0× 140 1.7× 88 1.1× 106 1.5× 35 650
Rose Nganga United States 7 319 0.7× 107 0.8× 63 0.8× 45 0.5× 55 0.8× 9 414
Florencia Cano United Kingdom 15 418 0.9× 67 0.5× 68 0.8× 69 0.8× 135 1.9× 20 608
Daniela Bressanin Italy 15 515 1.1× 71 0.6× 84 1.0× 132 1.6× 68 0.9× 26 784
Qi-Heng Yang United States 9 774 1.6× 142 1.1× 120 1.4× 144 1.7× 120 1.7× 13 951
Mengtao Xiao China 3 411 0.9× 113 0.9× 84 1.0× 49 0.6× 36 0.5× 7 573
Duran Sürün Germany 12 393 0.8× 92 0.7× 85 1.0× 51 0.6× 59 0.8× 25 493
А. С. Цимоха Russia 12 387 0.8× 114 0.9× 60 0.7× 111 1.3× 41 0.6× 39 468
Shivani Malik United States 15 665 1.4× 66 0.5× 79 1.0× 205 2.5× 63 0.9× 35 841
Ok Sun Bang South Korea 10 474 1.0× 73 0.6× 59 0.7× 165 2.0× 117 1.6× 11 628

Countries citing papers authored by Raquela J. Thomas

Since Specialization
Citations

This map shows the geographic impact of Raquela J. Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raquela J. Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raquela J. Thomas more than expected).

Fields of papers citing papers by Raquela J. Thomas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raquela J. Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raquela J. Thomas. The network helps show where Raquela J. Thomas may publish in the future.

Co-authorship network of co-authors of Raquela J. Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of Raquela J. Thomas. A scholar is included among the top collaborators of Raquela J. Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raquela J. Thomas. Raquela J. Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Thomas, Raquela J., et al.. (2023). Oncolytic myxoma virus is effective in murine models of triple negative breast cancer despite poor rates of infection. Molecular Therapy — Oncolytics. 30. 316–319. 4 indexed citations
2.
Thomas, Raquela J. & Eric Bartee. (2022). The use of oncolytic virotherapy in the neoadjuvant setting. Journal for ImmunoTherapy of Cancer. 10(4). e004462–e004462. 16 indexed citations
3.
Thomas, Raquela J., Natalia V. Oleinik, Shanmugam Panneer Selvam, et al.. (2017). HPV /E7 induces chemotherapy‐mediated tumor suppression by ceramide‐dependent mitophagy. EMBO Molecular Medicine. 9(8). 1030–1051. 48 indexed citations
4.
Gencer, Salih, Natalia V. Oleinik, Jisun Kim, et al.. (2017). TGF-β receptor I/II trafficking and signaling at primary cilia are inhibited by ceramide to attenuate cell migration and tumor metastasis. Science Signaling. 10(502). 67 indexed citations
5.
Dany, Mohammed, Salih Gencer, Rose Nganga, et al.. (2016). Targeting FLT3-ITD signaling mediates ceramide-dependent mitophagy and attenuates drug resistance in AML. Blood. 128(15). 1944–1958. 147 indexed citations
6.
Thomas, Raquela J., Natalia V. Oleinik, & Besim Öğretmen. (2016). HPV16‐E7 Oncoprotein Enhances Ceramide‐Mediated Lethal Mitophagy by Regulating the Rb/E2F5/Drp1 Signaling Axis. The FASEB Journal. 30(S1).
7.
Karlsson, Isabella, Xin Zhou, Raquela J. Thomas, et al.. (2015). Solenopsin A and analogs exhibit ceramide-like biological activity. PubMed. 7(1). 5–5. 21 indexed citations
8.
Colman, Daniel R., Raquela J. Thomas, Kendra Maas, & Cristina Takacs‐Vesbach. (2014). Detection and analysis of elusive members of a novel and diverse archaeal community within a thermal spring streamer consortium. Extremophiles. 19(2). 307–313. 16 indexed citations
9.
Saddoughi, Sahar A., Salih Gencer, Yuri K. Peterson, et al.. (2012). Sphingosine analogue drug FTY720 targets I2PP2A/SET and mediates lung tumour suppression via activation of PP2A‐RIPK1‐dependent necroptosis. EMBO Molecular Medicine. 5(1). 105–121. 223 indexed citations
10.
Meyers‐Needham, Marisa, Suriyan Ponnusamy, Salih Gencer, et al.. (2011). Concerted functions of HDAC1 and microRNA‐574‐5p repress alternatively spliced ceramide synthase 1 expression in human cancer cells. EMBO Molecular Medicine. 4(2). 78–92. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026